MARS: mutation-adjusted risk score for advanced systemic mastocytosis
1 ভিউ
administrator
07/09/23
Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
আরো দেখুন
ফেসবুক মন্তব্য
কোন মন্তব্য পাওয়া যায়নি